What is Cryoablation in Premature Ejaculation?
Premature ejaculation is one of the most common sexual dysfunctions in men. While behavioral therapies, local anesthetic creams, and systemic medications are widely used, cryoablation (freezing therapy) offers an innovative alternative for patients seeking long-term, drug-free solutions. Cryoablation is the controlled application of cold to hypersensitive dorsal nerve branches to optimize penile sensitivity.
Mechanism of Action of Cryoablation
This method is based on temporarily slowing down the conduction velocity of the targeted nerve fibers. The specialized cryoprobe used during the procedure suppresses hyperexcitability without damaging the nerve sheath. The targeted nerve tissue is frozen to approximately -40 to -60 degrees Celsius. This process works as follows:
- Raising the Sensory Threshold: Hypersensitivity in the glans penis is reduced, delaying the ejaculation reflex.
- Selective Nerve Blockade: Only the hypersensitive peripheral nerve endings are targeted, leaving motor functions and erectile capacity unaffected.
- Reversible Regeneration: The nerve fibers regenerate over time, during which the patient establishes a new habit of ejaculatory control.
Clinical Application Process and Stages
Cryoablation is a minimally invasive procedure rather than a major surgery. It can be performed easily under local anesthesia in an outpatient setting. The application steps are as follows:
- Pre-Evaluation and Mapping: The dorsal nerve areas where the patient exhibits hypersensitivity are identified using diagnostic tools like biothesiometry.
- Local Anesthesia: The procedure area is completely anesthetized to ensure maximum patient comfort.
- Cryoprobe Application: The targeted nerves are reached transcutaneously or via micro-incision, and freezing cycles are applied.
- Recovery Process: The procedure takes approximately 30-45 minutes, and the patient can return to daily activities on the same day.
Treatment Results and Success Rates
Clinical studies and patient follow-up data show a significant increase in intravaginal ejaculation latency time (IELT) following cryoablation. The outcomes observed after treatment generally show the following trends:
- Stabilization of penile sensitivity and increased control are observed within the first 2-4 weeks.
- In the majority of patients, sexual intercourse duration increases by 3 to 5 times.
- Side effects associated with drug use (headache, nausea, loss of libido) are entirely avoided.
- No negative impact on erectile quality has been reported.